HL

Hetalben Laljibhai Rudakiya

Active Director Designated Partner DIN 10706293
DIN 10706293 First appointment Jul 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Hetalben Laljibhai Rudakiya

Data last updated:

Hetalben Laljibhai Rudakiya is a Designated Partner at Hevnix Clinical Research Llp (since 2024).

DIN 10706293
Primary Designation Designated Partner
First Appointment 15 Jul 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner15 Jul 20242024Active

Board colleagues of Hetalben Laljibhai Rudakiya

NameDINCompanyDesignation
Anshul Agarwal10706291Hevnix Clinical Research LlpDesignated Partner
Nikhil Bharatbhai Khambhati10706292Hevnix Clinical Research LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Hevnix Clinical Research Llp
Premium access

Shareholding and investment profile for Hetalben Laljibhai Rudakiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hetalben Laljibhai Rudakiya

Hetalben Laljibhai Rudakiya currently holds 1 directorship: Hevnix Clinical Research Llp (Designated Partner, since 15 Jul 2024).

Hetalben Laljibhai Rudakiya was first appointed on 15 Jul 2024 as Designated Partner at Hevnix Clinical Research Llp.

The current boards of Hetalben Laljibhai Rudakiya's companies include Anshul Agarwal (Hevnix Clinical Research Llp), Nikhil Bharatbhai Khambhati (Hevnix Clinical Research Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available